Reuters: Common asthma drug cuts COVID-19 hospitalization risk, recovery time – Oxford study 10 February 2021 Health and Wellbeing The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalization by 90% when compared Read More
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial – The BMJ 3 April 2022